A Novel Biomarker Based on miRNA to Predict the Prognosis of Muscle-Invasive Bladder Urothelial Carcinoma

Figure 2

Kaplan–Meier curves and time-dependent receiver operating characteristic curves of miRNA signature. In the TCGA dataset, (a, b) the endpoint is overall survival and (c) the endpoint is progress-free interval. In the validation dataset, (d) the endpoint is overall survival; (e) time-dependent receiver operating characteristic curves of miRNA signature.

(a)

(b)

(c)

(d)

(e)